Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Orexigen_Therapeutics
|
| gptkbp:focusesOn |
obesity treatment
|
| gptkbp:foundedYear |
2018
|
| gptkbp:headquartersLocation |
gptkb:La_Jolla,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nalpropion Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:product |
gptkb:Contrave
gptkb:Mysimba |
| gptkbp:website |
https://www.nalpropion.com/
|
| gptkbp:bfsParent |
gptkb:Orexigen_Therapeutics
|
| gptkbp:bfsLayer |
7
|